Breaking News Instant updates and real-time market news.

EXAS

Exact Sciences

$19.28

0.06 (0.31%)

16:07
10/07/16
10/07
16:07
10/07/16
16:07

D.E. Shaw reports 5% passive stake in Exact Sciences

  • 26

    Oct

  • 15

    Nov

EXAS Exact Sciences
$19.28

0.06 (0.31%)

08/10/16
CHLM
08/10/16
NO CHANGE
Target $26
CHLM
Buy
Craig-Hallum positive on HCSC, Florida Blue coverage of Exact Sciences Cologuard
Craig-Hallum analyst Bill Bonello notes that two payors, namely Health Care Service Corporation, or HCSC, and Florida Blue posted updated Medical Policies indicating that Exact Sciences' Cologuard may be "medically necessary" for colorectal cancer screening. The analyst believes this is a "very positive" indicator of how other payors will interpret the positive recommendation from the U.S. Preventive Services Task Force issued in June. Further, he sees Exact Sciences as well positioned to become standard of care for colon cancer screening, which could be a $3B-$5B opportunity over time. Bonello reiterates a Buy rating and $26 price target on the shares.
08/15/16
ADAM
08/15/16
NO CHANGE
Target $24
ADAM
Buy
Exact Sciences price target raised to $24 from $19 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Exact Sciences to $24 from $19 citing expectations of ongoing commercial momentum in the second half of the year coupled with new commercial payor wins. Massaro raised its numbers based on recent payor wins and the belief Q3 guidance feels achievable. Massaro reiterated his Buy rating on Exact Sciences shares.
09/01/16
CHLM
09/01/16
NO CHANGE
Target $26
CHLM
Buy
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recommendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.
10/03/16
CHLM
10/03/16
NO CHANGE
CHLM
Craig-Hallum says to buy Exact Sciences
Craig-Hallum said it would be buyers of Exact Sciences following the inclusion of Colguard in Healthcare Effectiveness Data and Information Set, or HEDIS. The firm's analyst said HEDIS will drive both payor coverage and provider adoption of Cologuard as physicians now have a greater incentive to order Cologuard and payors have an increased incentive to facilitate Cologuard adoption.

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$80.17

0.16 (0.20%)

06:35
06/26/17
06/26
06:35
06/26/17
06:35
Initiation
LyondellBasell initiated  »

LyondellBasell initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$122.63

1.55 (1.28%)

, DDAIF

Daimler AG

$72.99

0.17 (0.23%)

06:34
06/26/17
06/26
06:34
06/26/17
06:34
Hot Stocks
Wabco signs long-term supply agreement with Daimler Trucks »

Holdings (WBC) announced…

WBC

Wabco

$122.63

1.55 (1.28%)

DDAIF

Daimler AG

$72.99

0.17 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

MTNB

Matinas BioPharma

$2.77

0.25 (9.92%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Conference/Events
Matinas BioPharma to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

EPZM

Epizyme

$14.70

1.05 (7.69%)

, RHHBY

Roche

$32.76

0.46 (1.42%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Hot Stocks
Epizyme expands clinical collaboration with Genentech »

Epizyme (EPZM) announced…

EPZM

Epizyme

$14.70

1.05 (7.69%)

RHHBY

Roche

$32.76

0.46 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

  • 30

    Jul

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

06:33
06/26/17
06/26
06:33
06/26/17
06:33
Upgrade
Pandora, SiriusXM rating change  »

Pandora upgraded to…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

SVU

Supervalu

$2.94

-0.04 (-1.34%)

06:31
06/26/17
06/26
06:31
06/26/17
06:31
Hot Stocks
Supervalu announces resignation of CFO Bruce Besanko »

Supervalu announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBS

RBS

$6.27

-0.03 (-0.48%)

06:30
06/26/17
06/26
06:30
06/26/17
06:30
Periodicals
RBS to cut 443 jobs in UK, move many of them to India, Reuters says »

Royal Bank of Scotland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

, GM

General Motors

$34.20

0.01 (0.03%)

06:27
06/26/17
06/26
06:27
06/26/17
06:27
Periodicals
Goldman's global head of equity capital markets to retire, Bloomberg reports »

Goldman Sachs' (GS)…

GS

Goldman Sachs

$217.19

-2.58 (-1.17%)

GM

General Motors

$34.20

0.01 (0.03%)

SQ

Square

$24.17

-0.11 (-0.45%)

AIG

AIG

$63.02

-0.03 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 18

    Jul

  • 25

    Jul

  • 03

    Aug

  • 17

    Oct

ALNY

Alnylam

$85.21

1.25 (1.49%)

06:26
06/26/17
06/26
06:26
06/26/17
06:26
Conference/Events
Alnylam to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 06

    Jul

GOOG

Alphabet

$965.59

8.5 (0.89%)

, GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

06:25
06/26/17
06/26
06:25
06/26/17
06:25
Periodicals
Nest's head of industrial design is leaving to join LVMH, Recode reports »

Rocky Jacob, head of…

GOOG

Alphabet

$965.59

8.5 (0.89%)

GOOGL

Alphabet Class A

$986.09

9.47 (0.97%)

LVMUY

LVMH

$51.86

0.24 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

VC

Visteon

$95.91

1.05 (1.11%)

06:23
06/26/17
06/26
06:23
06/26/17
06:23
Upgrade
Visteon rating change  »

Visteon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$71.21

0.95 (1.35%)

06:22
06/26/17
06/26
06:22
06/26/17
06:22
Periodicals
Microsoft Windows 10 source code leaked, The Register reports »

Microsoft suffered a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 20

    Jul

ENG

ENGlobal

$1.19

0.1 (9.17%)

06:21
06/26/17
06/26
06:21
06/26/17
06:21
Hot Stocks
ENGlobal announces strategic alliance with Coggins International »

ENGlobal Government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$32.76

0.46 (1.42%)

06:18
06/26/17
06/26
06:18
06/26/17
06:18
Hot Stocks
Genentech: Emicizumab showed reduction in bleeds across two pivotal studies »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

  • 30

    Jul

GM

General Motors

$34.20

0.01 (0.03%)

06:17
06/26/17
06/26
06:17
06/26/17
06:17
Periodicals
General Motors settles hundreds of ignition switch lawsuits, Reuters reports »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ILMN

Illumina

$185.28

2.29 (1.25%)

06:16
06/26/17
06/26
06:16
06/26/17
06:16
Hot Stocks
Genomics England adopts Illumina's BaseSpace variant interpreter for cancer »

Illumina and Genomics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical Co. Ltd.

$25.88

-0.04 (-0.15%)

06:15
06/26/17
06/26
06:15
06/26/17
06:15
Hot Stocks
Taked, Biological E. Limited to develop low-cost combination vaccines »

Takeda Pharmaceutical and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$55.54

-0.69 (-1.23%)

, VLKAY

Volkswagen

$30.63

-0.25 (-0.81%)

06:14
06/26/17
06/26
06:14
06/26/17
06:14
Periodicals
Harley-Davidson 'seriously considering bid' for Volkswagen's Ducati, WSJ says »

Harley-Davidson (HOG) is…

HOG

Harley-Davidson

$55.54

-0.69 (-1.23%)

VLKAY

Volkswagen

$30.63

-0.25 (-0.81%)

AUDVF

Audi AG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Oct

MMSI

Merit Medical

$37.80

0.7 (1.89%)

06:13
06/26/17
06/26
06:13
06/26/17
06:13
Recommendations
Merit Medical analyst commentary  »

Piper continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

SSNLF

Samsung

, QCOM

Qualcomm

$56.91

0.44 (0.78%)

06:10
06/26/17
06/26
06:10
06/26/17
06:10
Periodicals
Samsung to launch Galaxy Note8 in late September, VentureBeat says »

Samsung (SSNLF) is…

SSNLF

Samsung

QCOM

Qualcomm

$56.91

0.44 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ALNY

Alnylam

$85.21

1.25 (1.49%)

06:10
06/26/17
06/26
06:10
06/26/17
06:10
Hot Stocks
Alnylam: Givosian demonstrated decreased annual attack rate in study »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

CS

Credit Suisse

$13.74

-0.07 (-0.51%)

06:09
06/26/17
06/26
06:09
06/26/17
06:09
Initiation
Credit Suisse initiated  »

Credit Suisse resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

IBM

IBM

$154.11

-0.29 (-0.19%)

06:09
06/26/17
06/26
06:09
06/26/17
06:09
Hot Stocks
IBM, AEON to build blockchain-based financial platform for Asian market »

AEON Financial Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UBS

UBS

$16.06

-0.08 (-0.50%)

06:08
06/26/17
06/26
06:08
06/26/17
06:08
Upgrade
UBS rating change  »

UBS upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MTNB

Matinas BioPharma

$2.77

0.25 (9.92%)

06:07
06/26/17
06/26
06:07
06/26/17
06:07
Hot Stocks
Matinas: Clinical, mycological responses for MAT2203 didn't meet expectations »

Matinas BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.